{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T13:48:53Z","timestamp":1747403333257},"reference-count":24,"publisher":"Japanese Association for Laboratory Animal Science","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp. Anim."],"published-print":{"date-parts":[[2018]]},"DOI":"10.1538\/expanim.18-0004","type":"journal-article","created":{"date-parts":[[2018,6,6]],"date-time":"2018-06-06T22:26:33Z","timestamp":1528323993000},"page":"487-492","source":"Crossref","is-referenced-by-count":5,"title":["Association between &lt;i&gt;Helicobacter pylori&lt;\/i&gt; infection and platelet count in mice"],"prefix":"10.1538","volume":"67","author":[{"given":"Teruko","family":"Fukuda","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory Medicine, Teikyo University, 2-1-11 Kaga, Itabashi, Tokyo 173-8605, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eri","family":"Asou","sequence":"additional","affiliation":[{"name":"Teikyo University Hospital, 2-1-11 Kaga, Itabashi, Tokyo 173-0005, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimiko","family":"Nogi","sequence":"additional","affiliation":[{"name":"Teikyo University Hospital, 2-1-11 Kaga, Itabashi, Tokyo 173-0005, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Yasuda","sequence":"additional","affiliation":[{"name":"Pathological Analysis Center, Central Institute for Experimental Animals, 3-25-12 Tonomachi, Kawasaki-ku, Kawasaki 210-0821, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Goto","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory Medicine, Teikyo University, 2-1-11 Kaga, Itabashi, Tokyo 173-8605, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"439","reference":[{"key":"1","unstructured":"1. An R. and Wang P.P. 2017. Length of stay, hospitalization cost, and in-hospital mortality in US adult inpatients with immune thrombocytopenic purpura, 2006\u20132012. <i>Vasc. Health Risk Manag.<\/i> 13: 15\u201321."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Asahi A., Nishimoto T., Okazaki Y., Suzuki H., Masaoka T., Kawakami Y., Ikeda Y., and Kuwana M. 2008. <i>Helicobacter pylori<\/i> eradication shifts monocyte Fcgamma receptor balance toward inhibitory FcgammaRIIB in immune thrombocytopenic purpura patients. <i>J. Clin. Invest.<\/i> 118: 2939\u20132949.","DOI":"10.1172\/JCI34496"},{"key":"3","unstructured":"3. Aslam R., Kapur R., Segel G.B., Guo L., Zufferey A., Ni H., and Semple J.W. 2016. The spleen dictates platelet destruction, anti-platelet antibody production, and lymphocyte distribution patterns in a murine model of immune thrombocytopenia. <i>Exp. Hematol.<\/i> 44: 924\u2013930.e1."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Black C., Kaye J.A., and Jick H. 2003. MMR vaccine and idiopathic thrombocytopaenic purpura. <i>Br. J. Clin. Pharmacol.<\/i> 55: 107\u2013111.","DOI":"10.1046\/j.1365-2125.2003.01790.x"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Cheng Y.S., Kuang L.P., Zhuang C.L., Jiang J.D., and Shi M. 2015. Effects of cytotoxin-associated gene A (CagA) positive <i>Helicobacter pylori<\/i> infection on anti-platelet glycoprotein antibody producing B cells in patients with primary idiopathic thrombocytopenic purpura (ITP). <i>Pak. J. Med. Sci.<\/i> 31: 121\u2013126.","DOI":"10.12669\/pjms.311.6409"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Cines D.B. and Blanchette V.S. 2002. Immune thrombocytopenic purpura. <i>N. Engl. J. Med.<\/i> 346: 995\u20131008.","DOI":"10.1056\/NEJMra010501"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Cines D.B., Bussel J.B., Liebman H.A., and Luning Prak E.T. 2009. The ITP syndrome: pathogenic and clinical diversity. <i>Blood<\/i> 113: 6511\u20136521.","DOI":"10.1182\/blood-2009-01-129155"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Gasbarrini A., Franceschi F., Tartaglione R., Landolfi R., Pola P., and Gasbarrini G. 1998. Regression of autoimmune thrombocytopenia after eradication of <i>Helicobacter pylori<\/i>. <i>Lancet<\/i> 352: 878.","DOI":"10.1016\/S0140-6736(05)60004-9"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Goto K., Jiang W., Zheng Q., Oku Y., Kamiya H., Itoh T., and Ito M. 2004. Epidemiology of <i>Helicobacter<\/i> infection in wild rodents in the Xinjiang-Uygur autonomous region of China. <i>Curr. Microbiol.<\/i> 49: 221\u2013223.","DOI":"10.1007\/s00284-004-4287-6"},{"key":"10","unstructured":"10. Hanafy E. and Pakra M.A. 2017. Immune Thrombocytopenia and Obesity: Predictive Relationship. <i>Ochsner J.<\/i> 17: 115\u2013117."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Hopkins L.M., Davis J.M., Buchli R., Vangundy R.S., Schwartz K.A., and Gerlach J.A. 2005. MHC class I-associated peptides identified from normal platelets and from individuals with idiopathic thrombocytopenic purpura. <i>Hum. Immunol.<\/i> 66: 874\u2013883.","DOI":"10.1016\/j.humimm.2005.06.004"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Hwang J.J., Lee D.H., Yoon H., Shin C.M., Park Y.S., and Kim N. 2016. The Effects of <i>Helicobacter pylori<\/i> Eradication Therapy for Chronic IdiopathicThrombocytopenic Purpura. <i>Gut Liver<\/i> 10: 356\u2013361.","DOI":"10.5009\/gnl14483"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Lee A., O\u2019Rourke J., De Ungria M.C., Robertson B., Daskalopoulos G., and Dixon M.F. 1997. A standardized mouse model of <i>Helicobacter pylori<\/i> infection: introducing the Sydney strain. <i>Gastroenterology<\/i> 112: 1386\u20131397.","DOI":"10.1016\/S0016-5085(97)70155-0"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Lee J.Y., Lee J.H., Lee H., Kang B., Kim J.W., Kim S.H., Lee J.O., Kim J.W., Kim Y.J., Lee K.W., Kim J.H., Choi H.S., Lee J.S., and Bang S.M. 2017. Epidemiology and management of primary immune thrombocytopenia: A nationwide population-based study in Korea. <i>Thromb. Res.<\/i> 155: 86\u201391.","DOI":"10.1016\/j.thromres.2017.05.010"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Marta G.N. and de Campos F.P. 2015. Immune thrombocytopenia and autoimmune thyroid disease: a controversial overlap. <i>Autops. Case Rep.<\/i> 5: 45\u201348.","DOI":"10.4322\/acr.2015.002"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Nazi I., Kelton J.G., Larch\u00e9 M., Snider D.P., Heddle N.M., Crowther M.A., Cook R.J., Tinmouth A.T., Mangel J., and Arnold D.M. 2013. The effect of rituximab on vaccine responses in patients with immune thrombocytopenia. <i>Blood<\/i> 122: 1946\u20131953.","DOI":"10.1182\/blood-2013-04-494096"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Negi R.R., Bhoria P., Pahuja A., Saikia B., Varma N., Malhotra P., Varma S., and Luthra-Guptasarma M. 2012. Investigation of the possible association between the HLA antigens and idiopathic thrombocytopenic purpura (ITP). <i>Immunol. Invest.<\/i> 41: 117\u2013128.","DOI":"10.3109\/08820139.2011.593218"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Ninfea J.I., Basquiera A.L., Tabares A.H., Mas L., Alvarellos T., and Garcia J.J. 2012. Immune thrombocytopenia with antiphospholipid antibodies in monozygotic twins. <i>Platelets<\/i> 23: 309\u2013311.","DOI":"10.3109\/09537104.2011.615421"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Olsson B., Andersson P.O., Jern\u00c5s M., Jacobsson S., Carlsson B., Carlsson L.M., and Wadenvik H. 2003. T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura. <i>Nat. Med.<\/i> 9: 1123\u20131124.","DOI":"10.1038\/nm921"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Psaila B. and Bussel J.B. 2007. Immune thrombocytopenic purpura. <i>Hematol. Oncol. Clin. North Am.<\/i> 21: 743\u2013759, vii.","DOI":"10.1016\/j.hoc.2007.06.007"},{"key":"21","unstructured":"21. Schattner A. 2005. Consequence or coincidence? The occurrence, pathogenesis and significance of autoimmune manifestations after viral vaccines. <i>Vaccine<\/i> 23: 3876\u20133886."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Takahashi T., Yujiri T., Shinohara K., Inoue Y., Sato Y., Fujii Y., Okubo M., Zaitsu Y., Ariyoshi K., Nakamura Y., Nawata R., Oka Y., Shirai M., and Tanizawa Y. 2004. Molecular mimicry by <i>Helicobacter pylori<\/i> CagA protein may be involved in the pathogenesis of <i>H. pylori<\/i>-associated chronic idiopathic thrombocytopenic purpura. <i>Br. J. Haematol.<\/i> 124: 91\u201396.","DOI":"10.1046\/j.1365-2141.2003.04735.x"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Thompson L.J., Danon S.J., Wilson J.E., O\u2019Rourke J.L., Salama N.R., Falkow S., Mitchell H., and Lee A. 2004. Chronic <i>Helicobacter pylori<\/i> infection with Sydney strain 1 and a newly identified mouse-adapted strain (Sydney strain 2000) in C57BL\/6 and BALB\/c mice. <i>Infect. Immun.<\/i> 72: 4668\u20134679.","DOI":"10.1128\/IAI.72.8.4668-4679.2004"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Veneri D., De Matteis G., Solero P., Federici F., Zanuso C., Guizzardi E., Arena S., Gaio M., Pontiero P., Ricetti M.M., and Franchini M. 2005. Analysis of B- and T-cell clonality and HLA class II alleles in patients with idiopathic thrombocytopenic purpura: correlation with Helicobacter pylori infection and response to eradication treatment. <i>Platelets<\/i> 16: 307\u2013311.","DOI":"10.1080\/09537100400028685"}],"container-title":["Experimental Animals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/expanim\/67\/4\/67_18-0004\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,19]],"date-time":"2019-10-19T04:51:32Z","timestamp":1571460692000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/expanim\/67\/4\/67_18-0004\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1538\/expanim.18-0004","relation":{},"ISSN":["1341-1357","1881-7122"],"issn-type":[{"value":"1341-1357","type":"print"},{"value":"1881-7122","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}